Medical News

RSS

ArQule to present positive tivantinib Phase 2 clinical data for hepatocellular carcinoma

ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that an oral presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO) will feature Phase 2 trial data with tivantinib as a single agent investigational second-line treatment in hepatocellular carcinoma (HCC).

18 May 2012

Urocortin 2 improves cardiac output in Phase II study for acute decompensated heart failure

Neurocrine Biosciences, Inc. today announced efficacy and safety results from a Phase II trial of urocortin 2 in 53 patients with acute decompensated heart failure. The UNICORN study was conducted over approximately a two year period by the Cardioendocrine Research Group from the University of Otago in Christchurch, New Zealand and included patients admitted to Christchurch Hospital with acute decompensated heart failure.

18 May 2012

Personal genetic test results don't drive overuse of expensive medical care

People have more and more chances to participate in genetic testing that can indicate their range of risk for developing a disease. Receiving these results does not appreciably drive up- or diminish-test recipients' demand for potentially costly follow-up health services, according to a new study in the May 17, 2012 early online issue of Genetics in Medicine.

18 May 2012

Huffington Post series of opinion pieces examines NGO priorities for G8

The Huffington Post is running "a series of blogs by leading NGOs to call attention to a range of issues that should be raised at the G8 summit at Camp David in rural Maryland from May 18-19," according to the news service. The following summarizes some of the posts published this week.

18 May 2012

Breast cancer vaccine that elicits powerful immune response also improves recurrence rates

A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and is well tolerated in an adjuvant setting, according to new research from a clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.

18 May 2012

Decrease in rate of cigarette use among minors and young adults

A new report shows that while a significant segment of minors and young adults are still current smokers, there was a decrease in the rate of cigarette use among these populations between 2004 and 2010 (the year with the latest available data).

18 May 2012

Behavior-driven conditions are greatest contributors to health plan costs

Poor health choices add billions in cost to the companies, unions, health plans and government agencies that provide pharmacy benefits to Americans. In response, benefit providers are investing as never before to help people make better decisions to improve health outcomes, save money and maintain robust benefits, according to a report issued today by Express Scripts.

18 May 2012

First Edition: May 18, 2012

Today's headlines include a report that congressional conservatives are fighting amongst themselves over health law strategies.

18 May 2012

The truth about chocolate: does it really contain flavonoids?

There have been many news stories over the years about chocolate and whether it is good or bad for you. The stories often comment on a chemical constituent of chocolate: flavonoids. But what are flavonoids? Does chocolate even contain them? And why should we care if it does?

18 May 2012

Pharmacyclics announces clinical abstracts on ibrutinib to be presented at ASCO annual meeting

Pharmacyclics, Inc. today announced that clinical abstracts on Bruton's Tyrosine Kinase inhibitor, ibrutinib have been selected for oral presentations at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), June 1-5, 2012 in Chicago, IL.

18 May 2012

Health Canada approves Osiris’ Prochymal to treat acute GvHD in children

Osiris Therapeutics Inc. announced today it has received market authorization from Health Canada to market its stem cell therapy Prochymal (remestemcel-L), for the treatment of acute graft-vs-host disease (GvHD) in children.

18 May 2012

State budgets aim at health programs, Medicaid to bridge shortfalls

Medicaid and other health program cuts are on the minds of state lawmakers around the nation. In Maine, the governor signed Medicaid cuts into law Wednesday, and California and Kansas are weighing similar cuts as they struggle to balance their budgets.

18 May 2012

Regular eating times, extended daily fasting may prevent diabetes, obesity

It turns out that when we eat may be as important as what we eat. Scientists at the Salk Institute for Biological Studies have found that regular eating times and extending the daily fasting period may override the adverse health effects of a high-fat diet and prevent obesity, diabetes and liver disease in mice.

18 May 2012

Shimadzu expands Ultra Fast Mass Spectrometry product portfolio

Shimadzu Corporation today introduced the GCMS-TQ8030 ultra fast triple quadrupole gas chromatograph mass spectrometer, achieving the next step forward in Shimadzu's GC-MS history of innovation.

18 May 2012

WHO faces challenges in setting priorities

In this BMJ Groups Blog post, Amanda Glassman, director of Global Health Policy at the Center for Global Development, writes about the challenges the WHO faces in "setting priorities and fully funding those priorities."

18 May 2012

More than 55% of U.S. adults lose or break their sunglasses every year

More than 55 percent of adults in the United States lose or break their sunglasses every year, according to a new report by The Vision Council.

18 May 2012

Solantic to deploy PatientPoint HealthSync Platform

PatientPoint, a leading provider of care coordination and patient care management solutions, today announced that Solantic, the largest operator of urgent care centers in Florida, will be deploying the PatientPoint HealthSync Platform to improve patient outreach and access to care.

18 May 2012

Medtronic announces new results from CoreValve ADVANCE Study

Medtronic, Inc. today announced new results from the Medtronic CoreValve ADVANCE Study, which found that women and men benefitted similarly from the Medtronic CoreValve System.

From Medtronic 18 May 2012

Longer looks: Music as a means of treatment for PTSD

On one of the many days Leo Dunson wanted to die, the Iraq veteran put a gun to his temple and pulled the trigger. The loaded weapon misfired. For the troubled former soldier, it was another inexplicable failure, like his divorce or inability to make friends after returning from the war. In a Las Vegas recording studio, Dunson rapped about his life: "What's wrong with me? Got PTSD. These pills ain't working, man, I still can't think."

18 May 2012

Ipsen, Active Biotech to present data from tasquinimod phase II trial on CRPC at ASCO 2012

Active Biotech and Ipsen will present tasquinimod (TASQ), their prostate cancer drug candidate, at the scientific conference "2012 ASCO Annual Meeting" to be held in Chicago (USA) on 1-5 June 2012.

18 May 2012